Literature DB >> 9565089

Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection.

A M Waaga1, A Chandraker, M Spadafora-Ferreira, A R Iyengar, S J Khoury, C B Carpenter, M H Sayegh.   

Abstract

BACKGROUND: Recent evidence indicates that T cells primed via the indirect pathway of allorecognition play an important role in allograft rejection, although the effector mechanisms remain unknown. The purpose of this study was to characterize and study the in vivo function of self-restricted MHC allopeptide-specific T-cell clones generated from animals undergoing allograft rejection. METHODS AND
RESULTS: We generated self-restricted class II MHC allopeptide-specific T-cell clones from the spleen and kidney of Lewis (LEW; RT1l) rats undergoing acute rejection of MHC-incompatible Wistar Furth (WF; RT1u) renal allografts. RT1.Du/beta20-44 peptide-specific CD4+ T helper 1 clones from the spleen and kidney of rejecting animals expressed a restricted T cell receptor (TCR) Vbeta repertoire: Vbeta4, 8.2, or 9. In comparison, clones generated from RT1.Dubeta20-44 immunized LEW rats all expressed TCR Vbeta9. The amino acid sequence of RT1.Dl (LEW) and RT1.Du (WF) residues 20-44 differ only at positions 30 and 38. T-cell clones expressing TCR Vbeta9 preferentially proliferated to the peptide fragment RT1.Dubeta20-33. T-cell clones expressing TCR Vbeta4 proliferated weakly to peptide fragments RT1.Dubeta20-33 and 31-44, whereas those expressing TCR Vbeta8.2 proliferated preferentially to the peptide fragment 31-44. Adoptive transfer of T-cell clones expressing TCR Vbeta9 or Vbeta8.2, but not Vbeta4, to naive LEW animals elicited significant delayed-type hypersensitivity responses after challenge with the RT1.Dubeta20-44 peptide or allogeneic WF (RT1u) splenocytes.
CONCLUSION: This is the first report on the cellular, molecular, and functional characterization of self-restricted MHC allopeptide-specific T-cell clones from animals undergoing acute rejection. Our data provide support for a biologically significant role of indirect allorecognition in allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9565089     DOI: 10.1097/00007890-199804150-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.

Authors:  B Murphy; C C Magee; S I Alexander; A M Waaga; H W Snoeck; J P Vella; C B Carpenter; M H Sayegh
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.

Authors:  B A Pietra; A Wiseman; A Bolwerk; M Rizeq; R G Gill
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.

Authors:  Mao-Meng Tiao; Lina Lu; Ran Tao; Lianfu Wang; John J Fung; Shiguang Qian
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 4.  Molecular mechanisms of chronic rejection following transplantation.

Authors:  Elbert Kuo; Takahiro Maruyama; Felix Fernandez; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo.

Authors:  A M Waaga; M Gasser; J E Kist-van Holthe; N Najafian; A Müller; J P Vella; K L Womer; A Chandraker; S J Khoury; M H Sayegh
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

6.  Regulatory allospecific T cell clones abrogate chronic allograft rejection.

Authors:  Ana Maria Waaga-Gasser; Martin R Grimm; Jens Lutz; Volkmar Lange; Susanne M Lenhard; Beatriz Aviles; Joana E Kist-van Holthe; Tatiana Lebedeva; Dimitry Samsonov; Detlef Meyer; Wayne W Hancock; Uwe Heemann; Martin Gasser; Anil Chandraker
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

7.  Immunogenicity of parathyroid allografts in the rat: immunosuppressive dosages effective in passenger leukocyte-rich small bowel transplants are not effective in parathyroid gland transplants with few passenger leukocytes.

Authors:  S Timm; C Otto; D Begrich; V Moskalenko; W Hamelmann; K Ulrichs; A Thiede; W Timmermann
Journal:  Langenbecks Arch Surg       Date:  2003-12-05       Impact factor: 3.445

8.  Down regulation of CD45 expression on CD4 T cells during acute renal allograft rejection: evidence of a decline in T suppressor/inducer activity.

Authors:  M Shabtai; W C Waltzer; A Ayalon; E L Shabtai; K Malinowski
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.